Targets
Every human protein, and what every drug does to it
Coverage
- Every protein a drug acts on. The full reviewed human proteome, 20,500+ proteins, plus 2,100+ proteins from 575 other organisms — the bacterial, viral, and parasite targets of anti-infectives.
- Direction on every drug relationship. Agonist, antagonist, inhibitor, inducer, substrate, recorded per relationship.
- Binding strength where measured. Ki, Kd, IC50, and EC50 in nanomolar, each with the measurement and publication count behind it.
- Targets, enzymes, transporters, and channels. 5,400+ enzymes, 950+ transporters, 850+ GPCRs, and 590+ kinases.
Where it connects
Target record
Glucagon-like peptide 1 receptor
P43220
Drugs
Every approved, clinical-stage, and preclinical asset acting on it
nameSemaglutide
drugbank_idDB13928
action_typeagonist
pharmacological_actionyes
approval_statusapproved, investigational
modalityPeptides
+91 more drugs
Diseases
The indications those assets are aimed at
condition_titleType 2 Diabetes
condition_drugbank_idDBCOND0030616
ttd_strength_of_evidencePhase 3; Approved
opentargets_strength_of_evidencenull
combined_score1.4994
+492 more conditions
Clinical trials
Who's testing it, and at what phase
NCT07241390
NCT07551492
NCT07037459
NCT07165028
+2,769 more
NCT07241390
statusrecruiting
phase3
enrollment7140
start_date2025-12-01
Companies
Who owns those programs today
Via a registered trial
drugSemaglutide
sponsor.title (as filed)Novo Nordisk A/S
sponsor_company.name (resolved)Novo Nordisk
across 275 trials
Via a preclinical program
programDBPRG00174092
raw_phasepreclinical
company.name (resolved)Structure Therapeutics
+259 more programs
Zoom in
| drug | drug_drugbank_id | pharmacological_action | ec50 | ic50 | ki | kd | measurement_count |
|---|---|---|---|---|---|---|---|
| Semaglutide | DB13928 | yes | 0.019 | 1.97 | null | 441 | 6 |
| PF-06882961 | DB16043 | yes | 13.0 | null | 170 | 2.16 | 17 |
| Orforglipron | DB18964 | unknown | 26.8 | null | null | null | 2 |
| Lotiglipron | DB21631 | unknown | 4.04 | null | null | null | 2 |
| gene_name | uniprotkb_accession | protein_clique | pfams | residues | drugs |
|---|---|---|---|---|---|
| GLP1R | P43220 | G Protein Coupled Receptor | 7tm_2, HRM | 463 | 92 |
| GCGR | P47871 | G Protein Coupled Receptor | 7tm_2, HRM | 477 | 29 |
| GIPR | P48546 | G Protein Coupled Receptor | 7tm_2, HRM | 466 | 26 |
| ADCYAP1R1 | P41586 | G Protein Coupled Receptor | 7tm_2, HRM | 468 | 0 |
| pathway | pathway_drugbank_id | source | category |
|---|---|---|---|
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | DBPW00164797 | REACTOME | Metabolism |
| Incretins - Insulin release Pathway | DBPW00051695 | SMPDB | Physiological |
| Class B/2 (Secretin family receptors) | DBPW00164075 | REACTOME | Signal Transduction |
| G alpha (s) signalling events | DBPW00164735 | REACTOME | Signal Transduction |
| Integration of energy metabolism | DBPW00164965 | REACTOME | Metabolism |
+8 more pathways
| drug | drug_drugbank_id | enzyme | biodb_id | substrate | inhibitor |
|---|---|---|---|---|---|
| Semaglutide | DB13928 | Dipeptidyl peptidase 4 | BE0000854 | 1 | 0 |
| Semaglutide | DB13928 | Lipoprotein lipase | BE0000239 | 0 | 1 |
| Liraglutide | DB06655 | Neprilysin | BE0000266 | 1 | 0 |
| Exenatide | DB01276 | Dipeptidyl peptidase 4 | BE0000854 | 1 | 0 |
| Orforglipron | DB18964 | Cytochrome P450 3A4 | BE0002638 | 1 | 0 |
| Orforglipron | DB18964 | Cytochrome P450 2J2 | BE0003683 | 1 | 0 |
+3 more enzymes
| drug | drug_drugbank_id | protein | biodb_id | type | substrate |
|---|---|---|---|---|---|
| Orforglipron | DB18964 | Solute carrier organic anion transporter family member 1B1 | BE0001004 | TransporterBond | 1 |
| Orforglipron | DB18964 | ATP-dependent translocase ABCB1 | BE0001032 | TransporterBond | 1 |
| Orforglipron | DB18964 | Solute carrier organic anion transporter family member 1B3 | BE0003659 | TransporterBond | 1 |
| Semaglutide | DB13928 | Albumin | BE0000530 | CarrierBond | 1 |
| Liraglutide | DB06655 | Albumin | BE0000530 | CarrierBond | 0 |
| Tirzepatide | DB15171 | Albumin | BE0000530 | CarrierBond | 0 |
+1 more carrier relationship
| gene_name | cellular_location | transmembrane_regions | signal_regions | locus |
|---|---|---|---|---|
| GLP1R | Cell membrane | 7 spans, 140–404 | 1–23 | 6p21.2 |
| CYP3A4 | Endoplasmic reticulum membrane | 1 span, 2–22 | — | 7q22.1 |
| ABCB1 | Cell membrane | 12 spans, 45–977 | — | 7q21.12 |
| ALB | Secreted | — | 1–18 | 4q13.3 |
Questions it answers
- What else has been tried against this target, and what happened to it? Target diligence
- Who's working on this target before anyone has registered a trial? Target diligence
- Which validated targets could a different modality improve on? Modality-fit target discovery
All figures pulled as of November 2026.